Subscribe To
Kala pharmaceuticals to present at the jefferies healthcare conference
ARLINGTON, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to...
June 2, 2023, 12:00 pm
Kalvista pharmaceuticals to present data at the 2023 meeting of the european academy of allergy and clinical immunology (eaaci)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
June 2, 2023, 6:30 am
Hyliion holdings: accelerated commercialization
Hyliion Holdings Corp. is well-positioned for growth in the electric vehicle market, with strong demand from fleet operators and favorable regulations...
June 2, 2023, 3:38 am
Update — reneo pharmaceuticals to participate at the jefferies healthcare conference
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the d...
May 31, 2023, 2:38 pm
Aurora innovation: getting ready for commercialization
Aurora Innovation has made significant progress in its technology development, reaching key milestones such as completing Beta 6.0 for the Aurora Driv...
May 31, 2023, 3:36 am
Kaist and checkmate capital complete investment in bredis healthcare
Investment Accelerates Bredis’ Capacity Expansion, Integrated Platform Development and commercialization...
May 25, 2023, 10:00 pm
Theratechnologies to present preliminary safety and efficacy data from phase 1 trial of sudocetaxel zendusortide in heavily pretreated cancer patients at asco 2023
MONTREAL, May 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharma...
May 25, 2023, 5:31 pm
Nkgen announces poster presentation at the 2023 american society of clinical oncology (asco) annual meeting
SANTA ANA, Calif., May 25, 2023 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the developme...
May 25, 2023, 5:05 pm
Automaker stellantis invests in lyten, a silicon valley-based manufacturer of lithium-sulfur ev batteries
(Kitco News) - Automaker Stellantis (NYSE: STLA) announced on Thursday that Stellantis Ventures invested in Lyten to accelerate the ...
May 25, 2023, 12:43 pm
Fuelcell energy secures $87mm in project financing
Led by Investec Bank plc; New Capital to Support Accelerated commercialization of Hydrogen Fuel Cell Te...
May 25, 2023, 12:41 pm
Lahey hospital & medical center agrees to become one of the u.s. sites for the liberty® robotic system’s first human trial
This Significant Achievement Represents Major Progression Toward Regulatory and commercialization Paths...
May 25, 2023, 12:40 pm
Teknova to participate in upcoming investor conference
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for t...
May 25, 2023, 12:00 pm
Ppg industries (ppg) & entrotech unveil paint films solutions
This alliance will position PPG Industries' (PPG) paint film product portfolio for expedited commercialization...
May 25, 2023, 8:31 am
Dr. burkhard blank joins mannkind as executive vice president of research & development and chief medical officer
DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and ...
May 24, 2023, 12:30 pm
Applied materials (amat) boosts semiconductor presence with epic
Applied Materials (AMAT) announces multi-billion-dollar investment in Equipment and Process Innovation and com...
May 23, 2023, 12:09 pm
Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
May 23, 2023, 6:30 am
Alimera (alim) up on deal with eyepoint for u.s. rights to yutiq
Alimera Sciences ALIM announced acquiring additional U.S. commercialization rights for 0.18 mg dose s...
May 19, 2023, 1:46 pm
Ultragenyx to present at the 2023 barclays – gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
May 19, 2023, 12:30 pm
Ultragenyx to present at the 2023 barclays - gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
May 19, 2023, 8:30 am
Ambrx appoints stephen glover as chairman of its board of directors
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company...
May 18, 2023, 8:05 pm